ClearPoint Neuro (CLPT) Accumulated Expenses (2011 - 2026)

ClearPoint Neuro (CLPT) has 16 years of Accumulated Expenses data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 53.14% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (up 53.14% YoY), and the FY2025 full-year result was $4.4 million, down 10.75% from the prior year.
• Accumulated Expenses fell to $3.0 million in Q1 2026, from $4.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $4.9 million in Q4 2024 to a low of $1.3 million in Q1 2022.
• A 5-year average of $2.7 million and a median of $2.8 million in 2022 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 65.76% in 2024 and fell 10.75% in 2025, its largest moves.
• Tracing CLPT's Accumulated Expenses over 5 years: stood at $2.8 million in 2022, then grew by 4.36% to $2.9 million in 2023, then surged by 65.76% to $4.9 million in 2024, then fell by 10.75% to $4.4 million in 2025, then slumped by 31.72% to $3.0 million in 2026.
• Business Quant data shows CLPT's Accumulated Expenses at $3.0 million in Q1 2026, $4.4 million in Q4 2025, and $3.5 million in Q3 2025.